Skip to main content
placeholder image

Paliperidone Palmitate (Invega Trinza®) 3-Monthly Formulation for Maintenance Treatment of Schizophrenia

Journal Article


Abstract


  • Schizophrenia is a chronic severe CNS disorder for which the hallmark symptom is disabling psychosis that alters

    perception, thoughts, and behaviour.1 Impaired cognition is an under-recognized symptom of schizophrenia that

    interferes with daily life. Compared with the general population, people with schizophrenia have lower rates of

    unemployment, marriage, and independent living. The functional impairment of schizophrenia contributes to

    its substantial disease burden.

Publication Date


  • 2017

Citation


  • Pai, N. B. (2017). Paliperidone Palmitate (Invega Trinza®) 3-Monthly Formulation for Maintenance Treatment of Schizophrenia. Research Review,

Abstract


  • Schizophrenia is a chronic severe CNS disorder for which the hallmark symptom is disabling psychosis that alters

    perception, thoughts, and behaviour.1 Impaired cognition is an under-recognized symptom of schizophrenia that

    interferes with daily life. Compared with the general population, people with schizophrenia have lower rates of

    unemployment, marriage, and independent living. The functional impairment of schizophrenia contributes to

    its substantial disease burden.

Publication Date


  • 2017

Citation


  • Pai, N. B. (2017). Paliperidone Palmitate (Invega Trinza®) 3-Monthly Formulation for Maintenance Treatment of Schizophrenia. Research Review,